Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4881253

CN(C1CCC(NCc2ccccn2)CC1)S(=O)(=O)c1ccc(Nc2nccc(Nc3ccc(F)cc3)n2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.41
KCNH2 Q12809 1/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
AURKA O14965 4/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
AURKB Q96GD4 1/20 0.37
PTGDR2 Q9Y5Y4 4/20 0.37
PTGDR Q13258 2/20 0.37
CDK4 P11802 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4623339 0.94 MAPT (0.43) MAPK8KCNH2MAPTKMT2AMEN1
Trifluoroacetic Acid SCHEMBL4876640 0.90 MAPK8 (0.36) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4883185 0.88 NAMPT (0.46) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4881085 0.88 PTK2 (0.38) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4884485 0.88 NAMPT (0.46) MAPK8GAA
Trifluoroacetic Acid SCHEMBL4876720 0.88 PTK2 (0.39) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4884964 0.88 PTK2 (0.39) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4886219 0.87 NAMPT (0.39) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4881263 0.87 MAPK8 (0.38) MAPK8MAPTKMT2AMEN1NPC1
Trifluoroacetic Acid SCHEMBL4886446 0.86 MAPK8 (0.40) MAPK8MAPTKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269170-A1 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors SANOFI-AVENTIS (FR) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269170-A1 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors NFKBIA, IKBKB, IKBKE MAPK8 290/4885KCNH2 3929/4885MAPT 3357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.